NPCE NeuroPace Inc

$14.71 -3.22%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

NeuroPace Inc (NPCE) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $505 million. Shares last traded at $14.71, 25.7% below their 52-week high. Over the past year the stock is up 57.2%. Net profit margin is -19.3%, below the peer median of -9.3%. Revenue grew 25.1% year over year.

Market Cap

$505M

Shares Out

34.3M

EPS (TTM)

$-1.63

P/E Ratio

—

P/S Ratio

5.11

P/B Ratio

42.49

Dividend / Share

—

Dividend Yield

—

52-Week High

$19.80

52-Week Low

$9.24

Volume

9,290

Avg Vol (3m)

9,425.365

Performance

+4.40%

+7.69%

-9.64%

+8.12%

YTD

-3.03%

+57.24%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.05

SMA (50)

$15.11

SMA (200)

$15.47

Price vs SMA50

-2.62%

Price vs SMA200

-4.89%

ATR (14)

$0.66

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$99M

Net Income

$-19M

Gross Margin

79.6%

Operating Margin

-15.3%

Net Margin

-19.3%

Return on Equity

-160.9%

Return on Assets

-19.7%

Current Ratio

4.94

Debt / Equity

4.97

Revenue Growth (YoY)

+25.1%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.38	2026-08-11
Q1 2026	$-0.20	2026-05-12
FY 2025	$-0.66	2026-03-03
Q3 2025	$-0.58	2025-11-04
Q2 2026	$-0.47	2026-08-11
Q1 2026	$-0.21	2026-05-12

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

NPCE vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

5.11 / 2.94 med

+74% premium

Net margin vs peers

-19.3% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.